Concepts (171)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 5 | 2026 | 1001 | 2.110 |
Why?
|
| Diet | 12 | 2025 | 826 | 1.920 |
Why?
|
| Cohort Studies | 32 | 2026 | 1759 | 1.900 |
Why?
|
| Dementia | 2 | 2026 | 160 | 1.680 |
Why?
|
| Risk Factors | 37 | 2026 | 3994 | 1.590 |
Why?
|
| Colorectal Neoplasms | 7 | 2019 | 512 | 1.540 |
Why?
|
| Aged | 50 | 2026 | 8214 | 1.470 |
Why?
|
| Feeding Behavior | 11 | 2017 | 469 | 1.440 |
Why?
|
| Prostatic Neoplasms | 10 | 2015 | 1092 | 1.410 |
Why?
|
| Prospective Studies | 19 | 2026 | 1600 | 1.350 |
Why?
|
| California | 17 | 2026 | 548 | 1.240 |
Why?
|
| Middle Aged | 50 | 2026 | 12222 | 1.210 |
Why?
|
| Mortality | 4 | 2017 | 175 | 1.200 |
Why?
|
| Breast Neoplasms | 14 | 2017 | 1723 | 1.080 |
Why?
|
| Diet, Vegetarian | 1 | 2026 | 7 | 0.980 |
Why?
|
| Hawaii | 21 | 2026 | 2011 | 0.970 |
Why?
|
| Proportional Hazards Models | 16 | 2025 | 518 | 0.970 |
Why?
|
| Neoplasms | 6 | 2021 | 1377 | 0.930 |
Why?
|
| Diet, Mediterranean | 2 | 2025 | 37 | 0.920 |
Why?
|
| Vitamins | 4 | 2011 | 81 | 0.890 |
Why?
|
| Dietary Supplements | 4 | 2011 | 213 | 0.810 |
Why?
|
| Body Mass Index | 9 | 2017 | 925 | 0.800 |
Why?
|
| Male | 40 | 2026 | 23409 | 0.790 |
Why?
|
| Receptors, Estrogen | 6 | 2016 | 183 | 0.770 |
Why?
|
| Humans | 59 | 2026 | 43102 | 0.770 |
Why?
|
| Female | 46 | 2026 | 24698 | 0.770 |
Why?
|
| Vitamin D | 3 | 2010 | 196 | 0.720 |
Why?
|
| Life Style | 4 | 2017 | 334 | 0.710 |
Why?
|
| Dietary Fats | 4 | 2011 | 117 | 0.670 |
Why?
|
| Menopause | 4 | 2016 | 64 | 0.650 |
Why?
|
| Follow-Up Studies | 9 | 2017 | 1067 | 0.580 |
Why?
|
| Nutrition Policy | 4 | 2008 | 64 | 0.560 |
Why?
|
| Calcium, Dietary | 3 | 2007 | 65 | 0.550 |
Why?
|
| Obesity | 8 | 2017 | 1151 | 0.550 |
Why?
|
| Isoflavones | 2 | 2009 | 132 | 0.550 |
Why?
|
| Coffee | 1 | 2017 | 20 | 0.520 |
Why?
|
| Drinking | 1 | 2017 | 37 | 0.520 |
Why?
|
| Rectal Neoplasms | 1 | 2017 | 20 | 0.520 |
Why?
|
| Health Status Indicators | 1 | 2017 | 90 | 0.500 |
Why?
|
| Antioxidants | 3 | 2013 | 443 | 0.490 |
Why?
|
| Dietary Fiber | 1 | 2016 | 51 | 0.480 |
Why?
|
| Hormone Replacement Therapy | 1 | 2016 | 49 | 0.480 |
Why?
|
| Smoking | 4 | 2016 | 1024 | 0.480 |
Why?
|
| Exercise | 3 | 2019 | 692 | 0.480 |
Why?
|
| Postmenopause | 4 | 2017 | 141 | 0.480 |
Why?
|
| Forecasting | 1 | 2016 | 136 | 0.480 |
Why?
|
| Risk Assessment | 3 | 2016 | 863 | 0.480 |
Why?
|
| Receptors, Progesterone | 3 | 2015 | 92 | 0.470 |
Why?
|
| Acculturation | 4 | 2005 | 205 | 0.470 |
Why?
|
| Cardiovascular Diseases | 3 | 2018 | 749 | 0.470 |
Why?
|
| Aspirin | 1 | 2016 | 89 | 0.470 |
Why?
|
| United States | 12 | 2024 | 5205 | 0.460 |
Why?
|
| Minerals | 4 | 2008 | 53 | 0.450 |
Why?
|
| Colonic Neoplasms | 1 | 2017 | 223 | 0.440 |
Why?
|
| Adenocarcinoma | 1 | 2017 | 291 | 0.430 |
Why?
|
| Case-Control Studies | 8 | 2016 | 1285 | 0.400 |
Why?
|
| Inflammation | 1 | 2018 | 758 | 0.390 |
Why?
|
| Carotenoids | 2 | 2013 | 74 | 0.380 |
Why?
|
| Vegetables | 2 | 2013 | 147 | 0.380 |
Why?
|
| Fruit | 2 | 2013 | 178 | 0.370 |
Why?
|
| Fatty Acids | 2 | 2014 | 134 | 0.370 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2013 | 89 | 0.370 |
Why?
|
| Meat | 3 | 2009 | 46 | 0.360 |
Why?
|
| Zinc | 1 | 2012 | 131 | 0.340 |
Why?
|
| Energy Intake | 3 | 2008 | 164 | 0.340 |
Why?
|
| Alcohol Drinking | 3 | 2015 | 609 | 0.330 |
Why?
|
| Dairy Products | 2 | 2007 | 34 | 0.330 |
Why?
|
| Nutritional Requirements | 3 | 2008 | 33 | 0.310 |
Why?
|
| Overweight | 1 | 2012 | 249 | 0.310 |
Why?
|
| Phytoestrogens | 1 | 2009 | 39 | 0.300 |
Why?
|
| Genistein | 1 | 2009 | 45 | 0.300 |
Why?
|
| Adult | 16 | 2021 | 13872 | 0.290 |
Why?
|
| Cause of Death | 3 | 2018 | 186 | 0.290 |
Why?
|
| Fabaceae | 1 | 2008 | 30 | 0.280 |
Why?
|
| Sex Factors | 3 | 2019 | 1028 | 0.280 |
Why?
|
| Weight Gain | 3 | 2017 | 139 | 0.270 |
Why?
|
| Diet Surveys | 5 | 2017 | 99 | 0.260 |
Why?
|
| Logistic Models | 6 | 2016 | 1009 | 0.250 |
Why?
|
| Nutritional Status | 2 | 2007 | 119 | 0.240 |
Why?
|
| Epidemiologic Studies | 1 | 2006 | 33 | 0.240 |
Why?
|
| Chronic Disease | 2 | 2007 | 549 | 0.230 |
Why?
|
| Emigration and Immigration | 1 | 2005 | 85 | 0.220 |
Why?
|
| Korea | 4 | 2005 | 37 | 0.220 |
Why?
|
| Adolescent Nutritional Physiological Phenomena | 1 | 2004 | 18 | 0.210 |
Why?
|
| Residence Characteristics | 2 | 2017 | 363 | 0.210 |
Why?
|
| Medicare | 2 | 2024 | 332 | 0.200 |
Why?
|
| Longitudinal Studies | 2 | 2026 | 1063 | 0.200 |
Why?
|
| Apolipoprotein E4 | 1 | 2024 | 67 | 0.200 |
Why?
|
| Prognosis | 4 | 2013 | 861 | 0.200 |
Why?
|
| Odds Ratio | 6 | 2016 | 587 | 0.190 |
Why?
|
| Incidence | 5 | 2016 | 1078 | 0.180 |
Why?
|
| Young Adult | 8 | 2016 | 5080 | 0.170 |
Why?
|
| Registries | 3 | 2015 | 437 | 0.170 |
Why?
|
| Nutrition Assessment | 2 | 2013 | 80 | 0.170 |
Why?
|
| Mothers | 1 | 2003 | 215 | 0.170 |
Why?
|
| Soy Foods | 2 | 2013 | 60 | 0.160 |
Why?
|
| Mammography | 2 | 2013 | 212 | 0.150 |
Why?
|
| Aged, 80 and over | 8 | 2022 | 2853 | 0.140 |
Why?
|
| Multiple Myeloma | 1 | 2016 | 48 | 0.120 |
Why?
|
| Menarche | 1 | 2015 | 15 | 0.120 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 146 | 0.110 |
Why?
|
| Neoplasm Staging | 2 | 2013 | 374 | 0.110 |
Why?
|
| Reproductive History | 1 | 2015 | 27 | 0.110 |
Why?
|
| Body Fat Distribution | 1 | 2015 | 26 | 0.110 |
Why?
|
| Los Angeles | 4 | 2013 | 394 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2017 | 760 | 0.110 |
Why?
|
| Diabetes Complications | 1 | 2015 | 102 | 0.110 |
Why?
|
| Population Surveillance | 1 | 2016 | 246 | 0.110 |
Why?
|
| beta Carotene | 1 | 2013 | 11 | 0.100 |
Why?
|
| Adolescent | 5 | 2015 | 6081 | 0.100 |
Why?
|
| Xanthophylls | 1 | 2013 | 21 | 0.100 |
Why?
|
| Folic Acid | 1 | 2013 | 49 | 0.100 |
Why?
|
| Vitamin E | 1 | 2013 | 62 | 0.100 |
Why?
|
| Survival Rate | 1 | 2013 | 355 | 0.090 |
Why?
|
| Mammary Glands, Human | 1 | 2013 | 40 | 0.090 |
Why?
|
| SEER Program | 2 | 2015 | 164 | 0.090 |
Why?
|
| Age Factors | 2 | 2015 | 1154 | 0.090 |
Why?
|
| Age Distribution | 1 | 2012 | 249 | 0.090 |
Why?
|
| Body Size | 1 | 2012 | 49 | 0.090 |
Why?
|
| Pancreatic Neoplasms | 1 | 2014 | 218 | 0.090 |
Why?
|
| Survival Analysis | 1 | 2012 | 368 | 0.090 |
Why?
|
| Child | 3 | 2015 | 3443 | 0.090 |
Why?
|
| Prevalence | 3 | 2016 | 1612 | 0.080 |
Why?
|
| Arylamine N-Acetyltransferase | 1 | 2009 | 26 | 0.080 |
Why?
|
| Heterocyclic Compounds | 1 | 2009 | 23 | 0.080 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2009 | 40 | 0.070 |
Why?
|
| Body Height | 1 | 2009 | 53 | 0.070 |
Why?
|
| Risk | 2 | 2009 | 287 | 0.070 |
Why?
|
| Isoenzymes | 1 | 2009 | 168 | 0.070 |
Why?
|
| Comorbidity | 1 | 2011 | 737 | 0.070 |
Why?
|
| Erythrocytes | 1 | 2008 | 126 | 0.070 |
Why?
|
| Likelihood Functions | 1 | 2007 | 62 | 0.070 |
Why?
|
| Factor Analysis, Statistical | 3 | 2017 | 162 | 0.070 |
Why?
|
| Japan | 1 | 2008 | 348 | 0.070 |
Why?
|
| Cell Membrane | 1 | 2008 | 403 | 0.060 |
Why?
|
| History, 21st Century | 1 | 2005 | 83 | 0.060 |
Why?
|
| History, 20th Century | 1 | 2005 | 121 | 0.060 |
Why?
|
| Cross-Cultural Comparison | 1 | 2005 | 111 | 0.060 |
Why?
|
| Health Behavior | 1 | 2009 | 575 | 0.050 |
Why?
|
| Cholesterol, Dietary | 1 | 2004 | 9 | 0.050 |
Why?
|
| Sodium, Dietary | 1 | 2004 | 22 | 0.050 |
Why?
|
| Diabetes Mellitus | 1 | 2009 | 539 | 0.050 |
Why?
|
| Dietary Carbohydrates | 1 | 2004 | 34 | 0.050 |
Why?
|
| Cross-Sectional Studies | 3 | 2008 | 3156 | 0.050 |
Why?
|
| Educational Status | 1 | 2005 | 339 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 1124 | 0.050 |
Why?
|
| Food Preferences | 1 | 2003 | 73 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 1081 | 0.050 |
Why?
|
| Social Class | 2 | 2017 | 291 | 0.040 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2022 | 203 | 0.040 |
Why?
|
| Apolipoproteins E | 1 | 2021 | 138 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2005 | 1234 | 0.040 |
Why?
|
| Confidence Intervals | 2 | 2013 | 162 | 0.040 |
Why?
|
| Eating | 1 | 2022 | 167 | 0.040 |
Why?
|
| Principal Component Analysis | 1 | 2017 | 87 | 0.030 |
Why?
|
| Parity | 1 | 2015 | 59 | 0.030 |
Why?
|
| Stearic Acids | 1 | 2014 | 7 | 0.030 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2014 | 14 | 0.030 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2014 | 34 | 0.030 |
Why?
|
| Animals | 2 | 2009 | 16992 | 0.030 |
Why?
|
| Breast Feeding | 1 | 2015 | 126 | 0.030 |
Why?
|
| Epidemiologic Methods | 1 | 2013 | 56 | 0.030 |
Why?
|
| Leisure Activities | 1 | 2013 | 41 | 0.020 |
Why?
|
| Body Composition | 1 | 2012 | 159 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2012 | 290 | 0.020 |
Why?
|
| Body Weight | 1 | 2012 | 429 | 0.020 |
Why?
|
| Pregnancy | 1 | 2015 | 1772 | 0.020 |
Why?
|
| Milk | 1 | 2009 | 56 | 0.020 |
Why?
|
| Time Factors | 1 | 2013 | 1857 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2008 | 638 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2009 | 863 | 0.010 |
Why?
|